Key result
Peptide hormone receptor defects drive multiple human disease states, including hormone resistance and genetic obesity.
Answers are grounded in this paper and cite their sources.
The receptor, the initial site of hormone interaction with the target cell, can be the focus of a disease process. As discovered in 1972, mice with testicular feminization and androgen resistance had an inborn deficiency of androgen receptors (9) and mice with genetic obesity and extreme insulin resistance had a severe but reversible deficiency of insulin receptors (21, 52). Since then it has become clear that the receptor is a target cell site that is frequently involved in human disease states. The receptors for peptide hormones that are involved in human disease are the focus of this review (37, 47-49).
No takes yet. Share an insight, caveat, or question.
Roth et al. (1982) conducted a review in Peptide hormone receptor alterations in human disease states. Peptide hormone receptor alterations was evaluated. Peptide hormone receptors on target cells are frequently involved in human disease states, including hormone resistance and genetic obesity.
Synapse has enriched 10 related papers. Consider them for comparative context: